AccelBio Labs

Startup

AccelBio is a pre-clinical CRO working to accelerate client success in drug discovery programs, devices and clinical diagnostics. We offer specialized services for in vivo drug testing and in vitro assay development for small and large molecules and biologics, and specifically RNA therapeutics including RNAi and CRISPR approaches. We have TA expertise in a wide range of diseases, and bring years of experience in immuno-oncology and CNS diseases. We provide a path to studies in drug efficacy, safety and toxicology profiling, as well as mechanism of action data in gene expression and targeting, protein interactions and cell signaling.